Check 35,000+ stocks against 26 valuation models and 37 quality factors

Oakridge International Ltd (OAK) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Oakridge International Ltd A$0.03, price A$0.06, upside -52.5%, quality 53 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? Yes
Add to watchlist

Healthcare · AU · ISIN AU0000146961

OI Thin data Sep 23, 2026

Oakridge International Ltd

OAK · AU

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value A$0.0304 · Strongly overvalued (−53%)

!Quality 53/100

!Mixed Growth (revenue 5y +15.4 %/yr)

!Thin margins · 5.5% net margin (TTM)

!Low debt · negative free cash flow

✓Ranks above peers (10/12)

!Narrow moat 43/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear A$0.0250 to bull A$0.0358 Growth analysisrevenue history, year by year Quality 53/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Oakridge International Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range A$0.0470 – A$0.4000 · fair‑value band A$0.0250 – A$0.0358 · the A$0.0640 price screens above the A$0.0304 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Oakridge International in your weekly email

Every Wednesday you see whether Oakridge International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities.

Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities. The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sectors, including hospitals, aged care, disability care, and supported independent living facilities. It is also involved in the development of Internet of Things technology. The company was formerly known as Xped Limited and changed its name to Oakridge International Limited in April 2021. Oakridge International Limited is based in Adelaide, Australia.

Stock analysis

Oakridge International Ltd (OAK) currently trades at A$0.0640, while our model-based Fair Value estimate is A$0.0304, implying the stock looks roughly 110.5% overvalued today.

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 91/100, which puts the evidence level at low.

Scenario range: A$0.0250 (bear) to A$0.0358 (bull), the price of A$0.0640 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Oakridge International Ltd reported revenue of A$2.2M in FY2024 versus A$909K in FY2020, a compound +25.2%/yr. Reported net income was −A$129K in FY2024.

Key figures

Market cap A$2.3M (≈ $1.6M) · P/E ratio 6.4 · P/S ratio 0.73 · EPS (TTM) A$0.0100 · Net margin −5.8% · Return on equity 17.2% · Return on assets (EBIT) −23.8% · Operating margin 9.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).

What moves the price

The share trades about 36% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −53%, OAK screens richer than that median.

Fair Value models

Bear A$0.0250 Fair Value A$0.0304 Bull A$0.0358

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (A$0.0100 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

NCAV (Graham) A$0.0100 A$0.0200 A$0.0300 52

All 1 models by family

Asset-Based

NCAV (Graham) A$0.0100 A$0.0200 A$0.0300 52

Open the full fair value analysis →

Notify me when OAK reaches fair value

Put OAK on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 53/100

Of which business quality 51 · Market factors (momentum, volatility) 21

Profitability 40

Margins and returns on capital today

Quality Growth 80

Are margins and returns improving?

Cashflow 33

Earnings quality: real cash, not paper profit

Fin. Strength 70

Balance sheet, leverage, solvency risk

Investment 100

Disciplined investing over empire-building

Low Volatility 24

Calm price path (market factor)

Momentum 26

Price trend over the last 3–12 months (market factor)

52W Momentum 12

Distance to the 52-week high (market factor)

Net Issuance 0

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 54/100

Revenue is growing, but margins or cash flow do not fully confirm the trend.

Revenue growth 1 year

+173.7%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+65.0%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+15.4%

Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+19.4%

’14

’16

’17

’18

’19

’20

’21

’22

’23

’24

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

−132.8% (2019) → −29.2% (2024)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss

not computed

OAK screens 111% overvalued. Compare with Veeva Systems Inc →

Compare Oakridge International Ltd with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks

Beats the industry median on 9/11 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 51 · Below median

Fair Value upside −53% · Below median

Profitability

Return on equity (TTM) 17% · Top 25%

Return on assets 3% · Above median

Net margin (TTM) 5% · Above median

Operating margin (TTM) 10% · Above median

Growth and dividend

Revenue growth 62% · Top 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (TTM) 6.4× · Cheapest 25%

P/B 1.77× · Cheaper than median

P/S (TTM) 0.51× · Cheapest 25%

EV/EBITDA 9.6× · Cheapest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 3

FUTURE (revenue growth)100 · sector 34

PAST (return on equity)69 · sector 5

HEALTH (low debt)100 · sector 98

DIVIDEND (yield)0 · sector 48

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Veeva Systems Inc VEEV	$270.75	$297.83	+10%
Pro Medicus Limited PME	A$161.31	A$64.50	−60%
BrightSpring Health Services, Inc BTSG	$56.55	$26.07	−54%
HealthEquity, Inc HQY	$91.75	$100.93	+10%
Hinge Health, Inc HNGE	$94.15	$51.66	−45%
10x Genomics, Inc TXG	$80.70	$21.71	−73%
Waystar Holding WAY	$25.63	$28.19	+10%
XtalPi Holdings 2228	HK$8.39	HK$1.50	−82%
Doximity, Inc DOCS	$26.51	$31.41	+18%
Privia Health Group PRVA	$19.46	$5.26	−73%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Oakridge International Ltd · Fair Value
A$0.0304 −111%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/OAK" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Oakridge International Ltd · Fair Value</span><br><b style="font-size:20px">A$0.0304</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−111%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Oakridge International Ltd Fair Value". https://www.fairvalue-calculator.com/stock/OAK

Frequently asked questions

Is Oakridge International Ltd (OAK) overvalued or undervalued?

As of Sep 23, 2026, our model estimates a fair value of A$0.0304 versus a price of A$0.0640, about −53% upside (overvalued).

What is the fair value of OAK?

Our model-based fair value for Oakridge International Ltd is A$0.0304 (as of Sep 23, 2026), built from audited fundamentals. The current price: A$0.0640.

What is the quality score of OAK?

Oakridge International Ltd has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Oakridge International Ltd (OAK)?

Our model-based price target is the fair value of A$0.0304 (as of Sep 23, 2026) from 1 valuation models. Cautious scenario A$0.0250, optimistic scenario A$0.0358. It is a calculation from audited fundamentals, not an analyst target.

What is the Oakridge International Ltd stock forecast for 2026?

Our models put fair value at A$0.0304, about −53% upside versus a price of A$0.0640 (overvalued). Cautious scenario A$0.0250, optimistic scenario A$0.0358. The calculation is refreshed regularly with new filings.

What is the revenue of Oakridge International Ltd (OAK)?

Oakridge International Ltd reported trailing-twelve-month revenue of about A$3.1M (latest available figure, as of Sep 23, 2026).

What is the intrinsic value of Oakridge International Ltd (OAK)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Oakridge International Ltd it is A$0.0304 per share (as of Sep 23, 2026), against a price of A$0.0640. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).

Is Oakridge International Ltd stock overvalued or undervalued in 2026?

As of Sep 23, 2026, OAK trades above its calculated fair value: price A$0.0640, fair value A$0.0304, a gap of about −53% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of OAK?

No. The price is what the market pays today (A$0.0640); the fair value is what the company's own numbers justify (A$0.0304). For Oakridge International Ltd the two are A$0.0336 per share apart. That gap is exactly why we show both numbers side by side.

How much is Oakridge International Ltd worth?

The market values Oakridge International Ltd at about A$2.3M (market capitalisation, as of Sep 23, 2026). Per share that is A$0.0640; our models calculate a fair value of A$0.0304 per share.

What do the bullish and bearish scenarios say about OAK?

Our models span a range for Oakridge International Ltd: cautious scenario A$0.0250, base A$0.0304, optimistic A$0.0358 per share (as of Sep 23, 2026, price A$0.0640). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of OAK?

Oakridge International Ltd trades at a price-to-earnings ratio of 6.4 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of A$0.0304 is built from several models across several years. Other multiples: P/B 1.8, P/S 0.5, EV/EBITDA 9.6.

How solid is the balance sheet of Oakridge International Ltd (OAK)?

Balance-sheet figures for Oakridge International Ltd (as of Sep 23, 2026): return on equity 17.2%. They feed the Quality Score of 53/100, which measures business quality independently of the share price.

How far is OAK from its 52-week high?

Oakridge International Ltd trades at A$0.0640, about 36% below its 52-week high of A$0.1000 and 7% above the low of A$0.0600 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0304 is for.

Which stocks are comparable to Oakridge International Ltd?

From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Oakridge International Ltd stock attractive at the current price?

The data as of Sep 23, 2026: price A$0.0640, calculated fair value A$0.0304 (−53%), Quality Score 53/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of OAK calculated?

We run Oakridge International Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.0304, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 13.0 % above its aggregate fair value. Oakridge International Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Oakridge International Ltd (OAK)?

The closing price on Sep 24, 2026 was A$0.0640. Our model-based fair value is A$0.0304, about −53% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Oakridge International Ltd right now?

The price sits above even our optimistic bull case (A$0.0358). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Oakridge International Ltd

How large is the market capitalisation of Oakridge International Ltd (OAK)?

The market capitalisation of Oakridge International Ltd is A$2.3M (≈ $1.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Oakridge International Ltd (OAK)?

The price-to-sales ratio of Oakridge International Ltd is 0.73 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Oakridge International Ltd (OAK)?

Earnings per share at Oakridge International Ltd are A$0.0100 (price ÷ EPS = P/E 6.4). Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Oakridge International Ltd (OAK)?

The net margin of Oakridge International Ltd is −5.8% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Oakridge International Ltd (OAK)?

The return on equity (ROE) of Oakridge International Ltd is 17.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Oakridge International Ltd (OAK)?

On an EBIT basis the return on assets of Oakridge International Ltd is −23.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Oakridge International Ltd (OAK)?

The operating margin of Oakridge International Ltd is 9.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Oakridge International Ltd (OAK)?

Revenue at Oakridge International Ltd is growing +61.9% versus a year earlier (3y avg +65.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How much free cash flow does Oakridge International Ltd (OAK) generate?

The free cash flow of Oakridge International Ltd is −A$396K (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net cash does Oakridge International Ltd (OAK) hold?

Oakridge International Ltd holds more cash than debt, A$267K net (fiscal year 2024). The company holds more cash than debt, a safety cushion.

Free · no account needed

Watch Oakridge International Ltd in the live analysis

One click puts Oakridge International Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.